LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 261 individual holdings. The top holdings are Amgen stock at 8.01%, Vertex Pharmaceuticals at 8.00%, Gilead Sciences at 7.36%, Regeneron Pharmaceuticals at 4.90%, and Revolution Medicines at 2.78%.

Total Holdings

261

Top 10 Percentage

41.24%

Asset Class

Equity

ETF Category

Health Care

Assets

782.39M

PE Ratio

24.86

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	8.01%	254,184
2	VRTX	Vertex Pharmaceuticals Incorporated	8.00%	191,284
3	GILD	Gilead Sciences, Inc.	7.36%	636,815
4	REGN	Regeneron Pharmaceuticals, Inc.	4.90%	84,105
5	RVMD	Revolution Medicines, Inc.	2.78%	173,560
6	ALNY	Alnylam Pharmaceuticals, Inc.	2.51%	108,997
7	BIIB	Biogen Inc.	2.14%	120,529
8	ILMN	Illumina, Inc.	1.98%	123,519
9	RPRX	Royalty Pharma plc	1.81%	361,884
10	ROIV	Roivant Sciences Ltd.	1.74%	587,203
11	MRNA	Moderna, Inc.	1.72%	323,932
12	ARGX	argenx SE	1.67%	22,528
13	INSM	Insmed Incorporated	1.65%	176,954
14	INCY	Incyte Corporation	1.65%	163,100
15	UTHR	United Therapeutics Corporation	1.60%	34,652
16	GH	Guardant Health, Inc.	1.45%	108,253
17	VTRS	Viatris Inc.	1.41%	950,728
18	NBIX	Neurocrine Biosciences, Inc.	1.21%	82,087
19	ASND	Ascendis Pharma A/S	1.13%	50,260
20	BBIO	BridgeBio Pharma, Inc.	1.12%	159,900
21	JAZZ	Jazz Pharmaceuticals plc	1.09%	51,222
22	MEDP	Medpace Holdings, Inc.	1.08%	23,328
23	EXEL	Exelixis, Inc.	0.99%	205,345
24	MDGL	Madrigal Pharmaceuticals, Inc.	0.89%	18,766
25	AXSM	Axsome Therapeutics, Inc.	0.83%	42,078

Showing 25 of 261 holdings

Subscribe to see the full list

Activate Now

As of Jul 17, 2026